Glenmark Pharmaceuticals

BSE : 532296 | NSE : GLENMARK

Industry : Pharmaceuticals | ISIN : INE935A01035 | FreeFloat : 55.00% | FnO : Yes | LotSize : 1150


Intellectual Capital (IC)13,600.01
Net Worth (NW)9,178.99
Intrinsic Worth (IW)22,779.00
Market Cap (MC)14,914.00
Economic Value Added-120.50
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)59.70%
IC Gross Margin (EBITDA/IC)17.99%
IC Net Margin (NPT/IC)9.57%
Knowledge Turnover (Sales/IC)0.92
Market to Intrinsic Value (MC/IW)0.65

As OfIntrinsic ValueMarket Price
31 Dec 2021Rs. 807.28Rs. 528.55
26 May 2022 ---- Rs. 393.65
7.10     1.80%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 397.46AccumulateSell on Rallies
KB > 50% : Yes50 DMA : Rs. 436.68
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-19
C
2563.47
2602.53
403.19
322.22
240.31
161.66
12.92
Jun-19
C
2322.88
2324.55
343.58
252.85
159.84
109.28
149.29
Sep-19
C
2815.04
2895.87
531.23
437.07
347.30
255.54
139.19
Dec-19
C
2735.56
2768.52
473.04
367.04
270.98
190.84
221.14
Mar-20
C
2767.49
2811.63
542.71
416.43
317.96
220.31
20.64
Jun-20
C
2344.79
2403.30
564.57
451.35
357.61
254.04
278.37
Sep-20
C
2952.48
2920.60
524.07
420.01
339.38
233.99
204.88
Dec-20
C
2786.76
2801.85
558.58
443.38
347.97
248.18
352.98
Mar-21
C
2859.90
2868.39
531.92
420.85
337.52
233.87
194.58
Jun-21
C
2964.90
3023.54
632.23
519.16
443.55
306.53
397.39
Sep-21
C
3147.45
3134.38
577.10
453.91
384.96
274.81
221.57
Dec-21
C
3173.41
3187.31
528.67
409.74
343.04
239.75
246.89
* C - Consolidated, S - Standalone